En español

Home › Tag Results
External link, please review our disclaimer.

Methamphetamine

NIDA Announces Avant-Garde Medication Development Awards

Dr. Thomas Kosten of Baylor College of Medicine and Dr. Peter Burkhard of the University of Connecticut are the recipients of NIDA’s 2011 Avant-Garde Awards for Innovative Medication Development Research. Dr. Kosten is developing a vaccine against methamphetamine abuse and Dr. Burkhard is developing a vaccine to counter nicotine addiction.

Tags:

NIDA creates easy-to-read website on drug abuse

Featured on Latest Science: 
Not featured

A new, easy-to-read website on drug abuse designed for adults with a low reading literacy level (eighth grade or below) was launched today by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.  The site, which provides plain language information on neuroscience, drug abuse prevention and treatment, is also a resource for adult literacy educators.  It has a simple design with a large default text size, motion graphic videos and other features that make it easy to read and use.

Tags:

Stimulant Abusers' Regard for Future Improves With Memory Training

Researchers correlate stimulant abusers’ improved performance on a memory training exerc ise with reductions in delay discounting.

Tags:

Marker for Neuronal Damage Resolves a Year after Methamphetamine

New results extend previous findings that some methamphetamine-induced neuronal damage resolves after a year of abstinence.

Tags:

Methamphetamine (Mind Over Matter)

Explains how methamphetamine acts in the body and the brain and what happens with long-term use of the drug.

Tags:

NIDA Avant-Garde-Medications Development Award winners announced

Scientists proposing to develop vaccines against methamphetamine and nicotine have been selected to receive NIDA's second Avant-Garde Awards for Innovative Medication Development Research. The two scientists, Dr. Thomas Kosten, of Baylor College of Medicine, Houston, and Dr. Peter Burkhard, of the University of Connecticut, Storrs, will each receive $500,000 per year for five years to support their research, according to the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

Tags:

Letter from the Director

The abuse of methamphetamine - a potent and highly addictive psychostimulant - is a very serious problem in the United States. Initially limited to Hawaii and western parts of the country, methamphetamine abuse continues to spread eastward, with rural and urban areas everywhere increasingly affected. According to one national survey, approximately 10 million people in the United States have tried methamphetamine at least once.

Tags:

Methamphetamine Abuse and Addiction (Research Reports)

Provides an overview of the latest scientific findings on methamphetamine, including short- and long-term health consequences, effects on pregnancy, and potential prevention and treatment options.

Tags:

Featured Publication

Featured Publication

Drugs, Brains, and Behavior - The Science of Addiction

As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.

Read more

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. NIH...Turning Discovery Into Health

National Institute on Drug Abuse   |   6001 Executive Boulevard, Room 5213   |   Bethesda, MD 20892-9561

Questions for our staff? E-mail information@nida.nih.gov or call 301-443-1124 (240-221-4007 en español).

Mobile Site